Skip to content

Clinical trials

Withdrawn Phase 1 Primary Myelofibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Phase: Phase 1 Status: Withdrawn Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20162
20171
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Northwestern University2
City of Hope Medical Center1
Lynk Pharmaceuticals Co., Ltd1
Medigene AG1
Novartis Pharmaceuticals1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis7
Polycythemia Vera4
Myeloproliferative Disorders3
Leukemia, Myeloid, Acute2
Myelodysplastic Syndromes2
Anemia1
Hematologic Neoplasms1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative1
Leukemia, Myelomonocytic, Chronic1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.